Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms.

De Monte C, Carradori S, Granese A, Di Pierro GB, Leonardo C, De Nunzio C.

BMC Urol. 2014 Aug 11;14:63. doi: 10.1186/1471-2490-14-63. Review.

2.

Serenoa Repens, lycopene and selenium: a triple therapeutic approach to manage benign prostatic hyperplasia.

Minutoli L, Bitto A, Squadrito F, Marini H, Irrera N, Morgia G, Passantino A, Altavilla D.

Curr Med Chem. 2013;20(10):1306-12. Review.

PMID:
23432584
3.

BPH in 2012: novel agents in treatment of BPH.

Chughtai B, Te A.

Nat Rev Urol. 2013 Feb;10(2):72-3. doi: 10.1038/nrurol.2012.250. Epub 2013 Jan 8. Review. No abstract available.

PMID:
23295239
4.

Serenoa repens for benign prostatic hyperplasia.

Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD001423. doi: 10.1002/14651858.CD001423.pub3. Review.

PMID:
23235581
5.

Dietary supplements for benign prostatic hyperplasia: an overview of systematic reviews.

Kim TH, Lim HJ, Kim MS, Lee MS.

Maturitas. 2012 Nov;73(3):180-5. doi: 10.1016/j.maturitas.2012.07.007. Epub 2012 Aug 9. Review.

PMID:
22883375
6.

Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review.

MacDonald R, Tacklind JW, Rutks I, Wilt TJ.

BJU Int. 2012 Jun;109(12):1756-61. doi: 10.1111/j.1464-410X.2012.11172.x. Epub 2012 May 2. Review.

7.

Serenoa repens in benign prostatic hypertrophy: analysis of 2 Italian studies.

Mantovani F.

Minerva Urol Nefrol. 2010 Dec;62(4):335-40.

PMID:
20944533
8.

Serenoa repens and benign prostatic hyperplasia: no more effective than placebo.

[No authors listed]

Prescrire Int. 2010 Aug;19(108):181-2. Review.

PMID:
20941857

Supplemental Content

Loading ...
Support Center